7EH3 image
Entry Detail
PDB ID:
7EH3
Keywords:
Title:
Structure of Nanobody Nb23 in solution using NMR spectroscopy
Biological Source:
Source Organism:
Host Organism:
PDB Version:
Deposition Date:
2021-03-28
Release Date:
2021-07-14
Method Details:
Experimental Method:
Conformers Calculated:
20
Conformers Submitted:
10
Selection Criteria:
structures with the least restraint violations
Macromolecular Entities
Polymer Type:polypeptide(L)
Description:Nb23
Chain IDs:A
Chain Length:136
Number of Molecules:1
Biological Source:Lama glama
Ligand Molecules
Primary Citation
Structure of Nanobody Nb23.
Molecules 26 ? ? (2021)
PMID: 34207949 DOI: 10.3390/molecules26123567

Abstact

BACKGROUND Nanobodies, or VHHs, are derived from heavy chain-only antibodies (hcAbs) found in camelids. They overcome some of the inherent limitations of monoclonal antibodies (mAbs) and derivatives thereof, due to their smaller molecular size and higher stability, and thus present an alternative to mAbs for therapeutic use. Two nanobodies, Nb23 and Nb24, have been shown to similarly inhibit the self-aggregation of very amyloidogenic variants of β2-microglobulin. Here, the structure of Nb23 was modeled with the Chemical-Shift (CS)-Rosetta server using chemical shift assignments from nuclear magnetic resonance (NMR) spectroscopy experiments, and used as prior knowledge in PONDEROSA restrained modeling based on experimentally assessed internuclear distances. Further validation was comparatively obtained with the results of molecular dynamics trajectories calculated from the resulting best energy-minimized Nb23 conformers. METHODS 2D and 3D NMR spectroscopy experiments were carried out to determine the assignment of the backbone and side chain hydrogen, nitrogen and carbon resonances to extract chemical shifts and interproton separations for restrained modeling. RESULTS The solution structure of isolated Nb23 nanobody was determined. CONCLUSIONS The structural analysis indicated that isolated Nb23 has a dynamic CDR3 loop distributed over different orientations with respect to Nb24, which could determine differences in target antigen affinity or complex lability.

Legend

Protein

Chemical

Disease

Primary Citation of related structures